While approved by the Medicines and Healthcare products Regulatory Agency, the Alzheimer’s drug failed to win the backing of the U.K.’s National Institute for Health and Care Excellence, which said that its benefits were “too small to justify the cost.”
As the biotech implements a more focused strategy for its Roctavian hemophilia A gene therapy, BioMarin has recruited two seasoned pharma executives to bolster its C-suite.
Elon Musk’s brain technology startup Neuralink said its implant, designed to allow paralyzed patients to use digital devices by thinking alone, is working well in a second trial patient.
Liquidia has filed a legal challenge to the U.S. Food and Drug Administration’s decision to grant a three-year exclusivity to United Therapeutics’ inhaled drug used to treat lung disorders, the drugmaker said on Thursday.
With the potential passage of the BIOSECURE Act looming, WuXi Biologics reported a 24% drop in net profit in the first half of 2024.
The Colorectal Cancer Alliance (Alliance), the leading nonprofit organization dedicated to ending colorectal cancer, has announced the appointment of two new senior leaders to its executive team.